Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022

Stock Price vs Company Growth
1d
0.2%
1w
0.7%
1m
6.6%
3m
20.4%
6m
2.9%
1y
16.2%
all
3.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 163 0.2%
132
196
Company Overview

Sales
8,869 Cr
Growth: 0.2%
Profit after Tax
-347 Cr
Growth: 88.0%
Mid Cap
21,754 Cr
P/S: 2.5x
Industry P/S: 2.6x
Fundamentals

Sales (Cr) ₹ 8,869
Growth 0.2%
EBITDA 10.4%
P/S 2.5x
Dividend 0.1%
P/E -66.2x
Book Value ₹ 61.3
PEG Ratio -427.3x
ROE -4.3%
P/B 2.7x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Investors (6)
Followers (2)